These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26530923)

  • 1. Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical Imaging.
    Medarova Z; Balcioglu M; Yigit MV
    Methods Mol Biol; 2016; 1372():163-79. PubMed ID: 26530923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
    Chen YC; Chang WH; Wang SJ; Hsieh WY
    J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheomelanin-coated iron oxide magnetic nanoparticles: a promising candidate for negative T2 contrast enhancement in magnetic resonance imaging.
    Zottis AD; Beltrame JM; Lara LR; Costa TG; Feldhaus MJ; Pedrosa RC; Ourique F; de Campos CE; Isoppo Ede A; da Silva Miranda F; Szpoganicz B
    Chem Commun (Camb); 2015 Jun; 51(56):11194-7. PubMed ID: 26073290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superstable Magnetic Nanoparticles in Conjugation with Near-Infrared Dye as a Multimodal Theranostic Platform.
    Zhou H; Hou X; Liu Y; Zhao T; Shang Q; Tang J; Liu J; Wang Y; Wu Q; Luo Z; Wang H; Chen C
    ACS Appl Mater Interfaces; 2016 Feb; 8(7):4424-33. PubMed ID: 26821997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.
    Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK
    Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging.
    Abakumov MA; Ternovoi SK; Mazhuga AG; Chekhonin VP; Demikhov EI; Pistrak AG; Konstantinov MV; Dmitriev DM; Myshkinis BY
    Bull Exp Biol Med; 2019 Jun; 167(2):272-274. PubMed ID: 31243671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro MRI of biodegradable hybrid (iron oxide/polycaprolactone) magnetic nanoparticles prepared via modified double emulsion evaporation mechanism.
    Ahmed N; Ahmad NM; Fessi H; Elaissari A
    Colloids Surf B Biointerfaces; 2015 Jun; 130():264-71. PubMed ID: 25960142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
    Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
    J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
    Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron oxide nanoparticle surface decorated with cRGD peptides for magnetic resonance imaging of brain tumors.
    Richard S; Boucher M; Lalatonne Y; Mériaux S; Motte L
    Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1515-1520. PubMed ID: 28017683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI.
    Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A
    Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual contrast magnetic resonance imaging tracking of iron-labeled cells in vivo.
    Wu S; Zhang L; Zhong J; Zhang Z
    Cytotherapy; 2010 Nov; 12(7):859-69. PubMed ID: 20184501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physico-chemical and toxicological characterization of iron-containing albumin nanoparticles as platforms for medical imaging.
    Rosenberger I; Schmithals C; Vandooren J; Bianchessi S; Milani P; Locatelli E; Israel LL; Hübner F; Matteoli M; Lellouche JP; Franchini MC; Passoni L; Scanziani E; Opdenakker G; Piiper A; Kreuter J
    J Control Release; 2014 Nov; 194():130-7. PubMed ID: 25173842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleophilic cross-linked, dextran coated iron oxide nanoparticles as basis for molecular imaging: synthesis, characterization, visualization and comparison with previous product.
    Borny R; Lechleitner T; Schmiedinger T; Hermann M; Tessadri R; Redhammer G; Neumüller J; Kerjaschki D; Berzaczy G; Erman G; Popovic M; Lammer J; Funovics M
    Contrast Media Mol Imaging; 2015; 10(1):18-27. PubMed ID: 24753451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI molecular imaging using GLUT1 antibody-Fe3O4 nanoparticles in the hemangioma animal model for differentiating infantile hemangioma from vascular malformation.
    Sohn CH; Park SP; Choi SH; Park SH; Kim S; Xu L; Kim SH; Hur JA; Choi J; Choi TH
    Nanomedicine; 2015 Jan; 11(1):127-35. PubMed ID: 25168935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalizable silica-based micron-sized iron oxide particles for cellular magnetic resonance imaging.
    Raschzok N; Langer CM; Schmidt C; Lerche KH; Billecke N; Nehls K; Schlüter NB; Leder A; Rohn S; Mogl MT; Lüdemann L; Stelter L; Teichgräber UK; Neuhaus P; Sauer IM
    Cell Transplant; 2013; 22(11):1959-70. PubMed ID: 23294541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization.
    Ohno K; Mori C; Akashi T; Yoshida S; Tago Y; Tsujii Y; Tabata Y
    Biomacromolecules; 2013 Oct; 14(10):3453-62. PubMed ID: 23957585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruptive chemical doping in a ferritin-based iron oxide nanoparticle to decrease r2 and enhance detection with T1-weighted MRI.
    Clavijo Jordan MV; Beeman SC; Baldelomar EJ; Bennett KM
    Contrast Media Mol Imaging; 2014; 9(5):323-32. PubMed ID: 24764110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
    Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
    Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice.
    Zhang L; Zhou H; Belzile O; Thorpe P; Zhao D
    J Control Release; 2014 Jun; 183():114-23. PubMed ID: 24698945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.